#United States #Las Vegas #Bank of America #Neurocrine Biosciences #Health Care Conference

Neurocrine Biosciences at the 2026 Bank of America Health Care Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) has announced that its leadership team will participate in the highly anticipated Bank of America Health Care Conference 2026. This significant event will take place on May 12, 2026, at 11:20 AM Pacific Time (2:20 PM Eastern Time) in Las Vegas, Nevada. The company's executives are expected to discuss their latest advancements in biopharmaceuticals and the ongoing research efforts focused on neurological, endocrine, psychiatric, and immunological disorders.

In addition to the live presentation, Neurocrine plans to provide a webcast accessible through their official investor relations website, which will allow stakeholders and interested parties to engage with the content remotely. A recording of the presentation will be available shortly after the event has concluded and will remain accessible for approximately one month, ensuring that those who may not be able to attend in real time can still gain insights into the discussions and findings shared.

About Neurocrine Biosciences

Neurocrine Biosciences is driven by a mission to relieve suffering and improve the quality of life for individuals facing challenging health conditions. With a commitment to pioneering treatment options for under-addressed medical needs, the company has developed a diverse portfolio of assets aimed at targeting complex disorders that significantly impact daily living.

Among its noteworthy FDA-approved therapies are treatments for tardive dyskinesia and chorea associated with Huntington's disease, as well as solutions for classic congenital adrenal hyperplasia and endometriosis, in collaboration with AbbVie. Through relentless dedication to scientific exploration, Neurocrine is focused on delivering life-changing products that enhance patient outcomes and provide new hope for those suffering from debilitating conditions.

With over three decades of experience, Neurocrine has cultivated a profound understanding of neuroscience and the intricate relationships between brain and body systems. This knowledge is invaluable in driving continuous innovation in their research and development activities. The company operates with the belief that everyone deserves advanced, brave science that aims to ease the burden of chronic diseases.

As Neurocrine gears up for this pivotal conference, the anticipation surrounding their presentation underscores their influential role in the biopharmaceutical sector. Attendees and viewers alike can expect to hear about exciting developments in their therapeutic pipeline, which includes multiple compounds currently in mid to late-stage clinical trials across key therapeutic areas. The company’s proactive approach to addressing unmet medical needs underlines their philosophy of patient-centered care.

Whether you are a healthcare professional, investor, or simply an interested party, the upcoming Bank of America Health Care Conference will serve as a critical platform for understanding the trajectory of Neurocrine Biosciences and its ongoing efforts to innovate within the health care landscape.

Stay tuned for further details and insights from Neurocrine as they continue to lead with purpose and commitment at this key industry event.

For additional information about Neurocrine Biosciences and to access the upcoming webcast, please visit their official website at neurocrine.com. Follow the company on social media platforms including LinkedIn, X (formerly Twitter), Facebook, and YouTube for real-time updates and further engagement.